GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Long-Term Debt

Nanjing Pharmaceutical Co (SHSE:600713) Long-Term Debt : ¥3,483 Mil (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Nanjing Pharmaceutical Co Long-Term Debt?

Nanjing Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥3,483 Mil.

Nanjing Pharmaceutical Co's quarterly Long-Term Debt increased from Sep. 2023 (¥2,110 Mil) to Dec. 2023 (¥2,118 Mil) and increased from Dec. 2023 (¥2,118 Mil) to Mar. 2024 (¥3,483 Mil).

Nanjing Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2021 (¥2,628 Mil) to Dec. 2022 (¥2,222 Mil) and declined from Dec. 2022 (¥2,222 Mil) to Dec. 2023 (¥2,118 Mil).


Nanjing Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Nanjing Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Pharmaceutical Co Long-Term Debt Chart

Nanjing Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1,026.98 2,628.40 2,221.65 2,117.78

Nanjing Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,300.16 3,302.91 2,109.77 2,117.78 3,482.93

Nanjing Pharmaceutical Co  (SHSE:600713) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Nanjing Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Nanjing Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Pharmaceutical Co (SHSE:600713) Business Description

Traded in Other Exchanges
N/A
Address
No. 486 Zhongshan East Road, Nanjing, Jiangsu, CHN, 210002
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Executives
Xiao Hong senior management
Peng Yu Ping senior management
She Ping Supervisors
Jiang Xiao Jun senior management
Teng Xue Wu senior management
Zhou Jian Jun senior management
Li Yi Director
Huang Yan Li Supervisors
Tang Jian Zhong senior management
Zhang Yan Hui senior management
Zhou Yao Ping Director
Wang Hui Qing senior management
He Jin Geng senior management
Ding Feng Jun Director
Liang Yu Tang Director

Nanjing Pharmaceutical Co (SHSE:600713) Headlines

No Headlines